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Abstract
Piglets reared in swine production in the USA undergo painful procedures that include castration,
tail docking, teeth clipping, and identification with ear notching or tagging. These procedures
are usually performed without pain mitigation. The objective of this project was to develop
recommendations for pain mitigation in 1- to 28-day-old piglets undergoing these procedures.
The National Pork Board funded project to develop recommendations for pain mitigation in
piglets. Recommendation development followed a defined multi-step process that included an
evidence summary and estimates of the efficacies of interventions. The results of a systematic
review of the interventions were reported in a companion paper. This manuscript describes the
recommendation development process and the final recommendations. Recommendations were
developed for three interventions (CO2/O2 general anesthesia, non-steroidal anti-inflammatory
drugs (NSAIDs), and lidocaine) for use during castration. The ability to make strong recom-
mendations was limited by low-quality evidence and strong certainty about variation in stake-
holder values and preferences. The panel strongly recommended against the use of a CO2/O2
general anesthesia mixture, weakly recommended for the use of NSAIDs and weakly recommended
against the use of lidocaine for pain mitigation during castration of 1- to 28-day-old piglets.
Keywords: Systematic review, animal welfare, swine, pain, castration, GRADE, piglets
1. Introduction and background
Consumers of animal products are increasingly interested
in the ethical and social dimensions of food production
(Botonaki et al., 2006; Wright and Middendorf, 2008;
Food and Agricultural Organization of the United Nations
(FAO), 2009). Both collectively and individually, the
American consumer has become more interested in the
production history of food as a form of ethical consumer-
ism (Singer et al., 2006). Recent public concerns regarding
the need to protect farm animals have led to increased
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efforts to establish and enforce animal welfare regulations
(Rauch and Sharp, 2005). Americans are concerned about
farm animal welfare, and act on their concerns via voting
initiatives and purchasing behaviors (Appleby, 2005;
Tonsor and Wolf, 2010). In November 2006 voters
overwhelmingly supported proposed animal welfare
regulations that appeared on state ballots. Support for
these regulations was often 60%. Voters in California
passed Proposition 2 in 2008, which regulates the housing
of gestating sows, egg-laying hens, and veal calves. In
2009, a majority of voters in Ohio supported the
establishment of a Livestock Care Standards Board (i.e.
Issue 2) to provide oversight of farm animal care practices
(Appleby, 2005; Singer and Mason, 2007; Tonsor and
Wolf, 2010). The positive responses to these initiatives
indicate that there is growing public demand for animal
welfare assurance. Animal welfare assurance programs
have been developed by food industry retailers, proces-
sors, producer groups, and private organizations.
However, the US public appears to believe that external
regulation is necessary. There is an apparent general lack
of confidence that the industry will self-regulate, and a
need for US animal industries to demonstrate that they are
addressing animal welfare issues (Mench, 2003; Swanson,
2008). The increase in state-level initiatives may result in
the development of federal farm animal welfare standards
that exceed Animal Welfare Act standards. For the swine
industry to retain its autonomy, a clear and coherent plan
that includes the scientific and ethical issues fundamental
to the animal welfare concerns of the public and of
producer groups should be developed. This process
begins with a critical assessment of accepted practices.
This report presents the results of a process used to
evaluate the scientific evidence and develop recommen-
dations for pain mitigation in piglets in reared by the US
swine industry. The objective of this project was to assess
the efficacy of products designed to mitigate pain in
piglets and to develop recommendations for their use.
During its first few days of life, a piglet reared by a US
swine producer might be castrated, have its tail docked,
its teeth clipped, and have notches or tags put into one or
both ears. The reasons for the use of these procedures
differ. Castration reduces boar taint and aggression as
a pig matures to a market weight. Most of the pigs reared
in pork-producing countries are castrated. Except for
breeding stock, male swine are usually surgically
castrated, but alternative methods are increasing in
availability. Tail docking prevents pigs from biting the
tails of their pen mates, but can result in tail infections,
abscess formation, and in severe cases, paralysis or death.
Management alternatives to tail docking that provide
consistent results are not available. Teeth clipping
reduces injury of mammary glands during nursing, and
of littermates during teat competition. Teeth clipping was
a common practice for many years, but has become less
widely used by the industry. Ear notch identification is a
unique means of individual pig identification for US breed
registries. The US government uses information from ear
notches to identify individual animals as they are moved
during production. A swine producer may use ear
notches to identify the animal’s date of birth or other
information useful for the management of individual or
groups of pigs.
The procedures that are performed on piglets are
considered to be painful for the animal. However, pain
mitigation is not routinely provided to piglets reared in
swine production in the USA. The reasons for this include
historical precedent, economic barriers, impracticality,
uncertainty about need, uncertainty about legality of the
use of analgesic drugs, and uncertainty about efficacy. In
response to the need for pain mitigation, the swine
industry has funded research during the past decade
to increase understanding about pain in piglets and to
develop pain mitigation methods.
Piglet processing procedures involve surgery, so two
phases of pain should be addressed during the use of an
intervention (Kissin, 2000; Gottschalk and Smith, 2001).
The pain that results from the incisional phase are
primarily neutrally mediated (i.e. electrical pulses to
receptors). The second, or prolonged inflammatory
phase, arises primarily due to tissue damage and is mostly
mediated by prostaglandin synthesis and cytokine
release. The goal of administering analgesic compounds
prior to castration is to mitigate both the incisional
(general anesthesia, local anesthesia) and inflammatory
(non-steroidal anti-inflammatory drugs (NSAIDs)) phases
of the pain response (Ochroch et al., 2003). Among the
interventions evaluated here, local and general anesthesia
are interventions that relieve pain during the incisional
phase. NSAIDs suppress inflammatory responses. Effec-
tive analgesia may require a multimodal approach using
compounds that act on different receptor targets along the
nociceptive pathway (Coetzee, 2013b).
2. Approach to the development of recommendations
Recommendation development is a multi-step process
Oxman et al. (2006). Transparent development of guide-
lines ensures that stakeholders are aware of the factors
that were considered during the process. The Grading of
Recommendations Assessment, Development and Evalua-
tion (GRADE) process was used during this project.
Examples of guidelines developed using this approach
have been published by the World Health Organization1,
the American College of Physicians2, the Agency for
Healthcare Research and Quality3, and the US Centers for
1http://www.who.int/influenza/human_animal_interface/
guidelines/pharmamanagement/en/
2http://www.gradeworkinggroup.org/publications/
Qaseem_ACP-COPD_Annals2007.pdf
3http://www.ahrq.gov/downloads/pub/evidence/pdf/phe/
phe.pdf
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Disease Control and Prevention4. The GRADE approach is
also extensively described in a series of publications, and
revised periodically (Balshem et al., 2011; Guyatt et al.,
2011a, b, c, d, e, f, g, h, 2012, 2013a, b, c; Andrews et al.,
2013a, b; Brunetti et al., 2013; Mustafa et al., 2013).
The GRADE approach was selected for this project
because it is a transparent process and includes diverse
and informed perspectives. The process acknowledges
the importance of scientific evidence and the potential for
biased scientific information. It articulates ethical and
non-ethical values and preferences that motivate recom-
mendations. A key concept in the development of
recommendations is that scientific evidence is global, but
decisions are local. Scientific evidence is considered to be
global in that if reviewers use the same approach for
searching, extracting, and analyzing data during the
review process, they typically arrive at the same conclu-
sions. Decision making is local in that it is informed by
local challenges, values, and preferences, and by the
limitations of a particular review process.
Recommendations are also affected by time and
available data and expertize. Changes in dynamic factors
(e.g. scientific evidence, social values, and preferences)
affect the balance of benefits and harms, so resource
allocation may change over time. The recommendations
developed during this project are a result of the current
state of knowledge, expertize, and resource availability.
Previously described approaches were used to develop
our recommendations (Schunemann et al., 2006b; Guyatt
et al., 2011g). The process consisted of 19 parts: (1)
establish priorities, (2) establish group composition and
consultations, (3) declare and avoid conflicts of interest,
(4) define group processes, (5) identify important
outcomes, (6) define the questions and eligibility criteria,
(7) determine study designs for different questions, (8)
identify evidence and clarify basic assumptions, (9)
synthesize and present evidence, (10) specify and
integrate values and preferences, (11) make judgments
about desirable and undesirable effects, (12) take account
of equity, (13) grade the evidence and recommendations,
(14) account for costs, (15) adapt, apply, and transfer
guidelines, (16) determine report structure, (17) deter-
mine methods of peer review, (18) plan dissemination
and implementation methods, and (19) evaluate the
guidelines (Schunemann et al., 2006b).
3. Scope of the recommendations and evidence
considered
The original project objective was to provide a total of 12
recommendations for the use of three interventions
(general anesthesia, NSAIDs, and local anesthesia) for
four procedures (castration, tail docking, teeth clipping,
and identification with ear notching or tagging). A
systematic review was performed to identify scientific
information to be used in the recommendation process
(Dzikamunhenga et al., 2014).
The results of the systematic review revealed that there
were few data available for some topics. Data were often
reported in a format that precluded summary and
quantification of results. Consequently, the steering
committee chose to present data from seven outcomes
at two time points (i.e. <60 min and 1–24 h after a
procedure) for consideration during the recommenda-
tion-making process. The outcomes were cortisol, nore-
pinephrine, and b-endorphin concentrations, frequency
or pitch (Hz) of vocalizations, energy or loudness (dB)
of vocalizations, vocalization rate or risk (the number of
vocalisations per piglet per unit time during and after
castration, or the percent of piglets that vocalized), and
frequency of pain-associated behaviors.
Only two studies (from the same publication) that
assessed pain mitigation related to teeth clipping and ear
notching were identified during the review. Because this
amount of data was insufficient for the development of
recommendations, these procedures were not included in
the process.
Only the results from trial arms (i.e. the group of piglets
receiving a certain type of therapy) using a single pain
mitigation strategy were included in the development of
recommendations. Publication of more than one study
from two or more authors was also necessary for an
intervention to be included in the recommendations.
Because of the limitations imposed by these criteria, the
scope of the recommendation making process was
narrower than originally intended. Three areas were
included in the recommendations. They were use of CO2/
O2 general anesthesia, use of lidocaine, and use of
NSAIDs, during castration of piglets. For these three areas,
there was sufficient number of independent studies for
only eight possible outcomes (Table 3). We developed
an evidence profile, a summary of findings table, and
a recommendations table for each intervention (as
suggested by GRADE guidelines).
4. Methods and processes for recommendation
development
Recommendations and guidelines for numerous animal
production topics are available e.g. euthanasia (https://
www.avma.org/KB/Policies/Documents/euthanasia.pdf;
biosecurity (https://webadmin.pork.org/filelibrary/Biose-
curity/final%20biosecurity%20book.pdf_)). However, exam-
ples of transparent approaches to the formal incorporation
of scientific information into the development of recom-
mendations are not available. The procedures used
during development of the recommendations are usually
not described. This information may not be necessary for
some non-controversial topics. However, experience4http://www.cdc.gov/vaccines/recs/acip/GRADE/about.htm
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from human health disciplines suggests that there is value
in adding such information so that end users are aware of
the process used for decision-making. The following
sections provide details about the development of the
recommendations that resulted from this project.
4.1 Priority setting
Priorities for development of a set of recommendations
are often established by a steering committee (Oxman
et al., 2006). In 2011, the National Pork Board Animal
Welfare Committee published a 5-year research strategy
to address the swine industry’s animal welfare priorities.
Pain management during piglet processing was identified
as a research priority. The National Pork Board Animal
Welfare Committee requested a literature review of piglet
processing procedures and pain management.
4.1.1 Group composition and consultation process
There were four groups of project participants (i.e. steering
committee, review team, external participants, and panel
members). Someof the participantsweremembers ofmore
than one group (Fretheim et al., 2006a) (Table 1). External
participants were invited to attend the recommendation
development meeting. The panel members were also
members of the steering committee or were external
participants, and had voting rights during the meeting. The
review team consisted of A. O’Connor, R. Dzikamunhenga,
and S. Gould. The review team members did not vote.
The steering committee determined the content,
methodological expertize, and stakeholder groups
needed during the project (Fretheim et al., 2006a)
(Table 1). Although published recommendations suggest
that group size should be limited to 15 members
(Fretheim et al., 2006a), the steering committee recom-
mended inviting 25 people. The final panel meeting
group consisted of 19 voting members. Four nongovern-
mental organizations associated with animal welfare
groups were invited to attend the February 2013 meeting,
but none were able to participate.
Project funding was received in August 2012, and
the review protocol was completed in December 2013.
Table 1. Expertize sections identified as necessary for the GRADE guidelines-making process, and the steering committee and
external panel members in each section
Expertize Participant and institution
Applied animal behavior Anna Johnson (Iowa State University, USA)1,2
Suzanne Millman (Iowa State University, USA)1,2
Jeremy Marchant-Forde (USDA-ARS, USA)2,3
Ed Pajor (University of Calgary, Canada)2,3
Kenny Rutherford (Scotland’s Rural College, UK)2,3
Animal and agricultural ethics Raymond Anthony (University of Alaska Anchorage, USA)2,3
Food production economics Glynn Tonsor (Kansas State University, USA)
Pharmacology Johann (Hans) Coetzee (Iowa State University, USA)1,2
Kip Lemke (University of Prince Edward Island, Canada)2,3
Stress physiology Sherrie Niekamp (National Pork Board, USA)2,1
Luciana Bergamasco (Virginia Tech, USA)2,3
Mhairi Sutherland (AgResearch Ltd, New Zealand)2,3
Eberhard von Borell (Martin-Luther-University Halle-Wittenberg, Germany)3,4
Study design and sources of bias Annette O’Connor (Iowa State University, USA)1,4
Rungano Dzikamunhenga (Iowa State University, USA)4
Locke Karriker (Iowa State University, USA)1,2
Hans Coetzee (Iowa State University, USA)1,2
Swine health and production Gene Noem (Murphy Brown Inc., USA)2,3
Brent Scholl (Scholl Farms, USA)2,3
Locke Karriker (Iowa State University, USA)2,1
Jim McKean (Iowa State University, USA)2,1
Guy Martineau (Ecole Nationale Veterinaire de Toulouse, France)2,3
Michelle Sprague (American Association of Swine Veterinarians, USA)2,3
Research synthesis and guideline
development
Annette O’Connor (Iowa State University, USA)
Explicitly targeted stakeholder groups
Animal welfare NGO Not represented (four individuals from four organizations were invited,
all declined to participate)
Organized veterinary medicine Michelle Sprague (American Association of Swine Veterinarians, USA)
Swine producer Gene Noem (Murphy Brown Inc., USA)
Brent Scholl (Scholl Farms, USA)
1Steering committee member.
2Voting panel member.
3External participant.
4Review team member.
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The steering committee meetings were in September 2012
(Steering Meeting 1) and January 2013 (Steering Meeting
2). The panel meeting was at the Renaissance Hotel, Des
Moines, Iowa, USA, from 12–14 February 2013 (2.5 days).
The panel meeting was chaired by the review coordi-
nator, Dr A. O’Connor (the facilitator).
4.1.2 Managing conflicts of interest
Conflict of interest statements were not required prior
to invitation or participation, but were required prior to
publication. The list of authors included only the
participants who provided a conflict of interest state-
ment.
4.1.3 Group processes
Group processes, the voting approach, and document
preparation followed published recommendations
(Fretheim et al., 2006b). Decisions made at steering
committee meetings (September 2012 and January 2013)
were made after discussion, but without formal voting. At
the February 2013 panel meeting, confidential voting and
vote tallies were completed using automated clickers. At
the panel meeting voters could not abstain, and a 75%
majority was required for approval of a recommended
intervention.
4.1.4 Identification of important outcomes for recom-
mendation making
The steering committee identified and nominated relevant
outcomes before the systematic review was initiated
(Dzikamunhenga et al., 2014). The list of outcomes was
shared with the external participants. They were also
invited to suggest additional outcomes. There were four
categories on the final list: behavioral outcomes (during
and within 60 min of a procedure), behavioral outcomes
(1–24 h after a procedure), non-behavioral outcomes
(during and within 60 min of a procedure), and non-
behavioral outcomes (1–4 h after a procedure) (Table 2).
In November 2012, panel members ranked the
outcomes (one (least important) to nine (most impor-
tant)) by completing an online questionnaire (Survey-
Monkey) (Guyatt et al., 2011c). Critical outcomes were
assigned values of 7–9. These outcomes were essential to
the decision-making process. In the context of this
review, critical outcomes were those for which it was
clear that the outcome was a measure of pain experience
rather than other responses, such as stress or fear.
Similarly, these may have been outcomes that more
directly measured the animal’s response in a cascading
pathway. For example, cortisol leads to a stress
leukogram; therefore, cortisol would be the more direct
measure. Important outcomes were assigned values of
4–6. Important outcomes were less essential to the
decision-making process. Non-important outcomes were
assigned values of 1–3. Non-important outcomes were
defined as outcomes that were unlikely to change the
decision-making process or inference. These outcomes
are often measured because the data are simple to collect
or are part of standard practice. However, they were not
considered to be truly relevant for the assessment of an
intervention, and were not included in the guideline
development process. The results of the survey were
summarized after outcome data were extracted from the
literature.
Note that one of the weaknesses of our ranking process
was that original survey designed by the review team
grouped the outcomes together for all procedures.
Although for general stress responses such as cortisol
these would all be expected to occur in each procedure.
The behavioral outcomes were more likely specific i.e.
wound guarding depends on the location of the insult,
and visceral pain responses associated with castration,
but not tail docking, etc. Similarly, ear flicking was ranked
highly but this is almost certainty because it was
considered important for ear notching. This likely resulted
in lower ranking of the behavioral outcomes and reflects
an error in the survey methodology.
4.1.5 Explicit definition of the question and eligibility
criteria
Dzikamunhenga et al., (2014) describes the systematic review
methodology. The parts of the review were determined a
priori and were described in a protocol. The steering
committee prepared the protocol. The specific review
question was, ‘In piglets that undergo castration, tail
docking, teeth clipping, and/or methods of identification
that involve cutting of the ear tissue, such as ear tagging
and ear notching (P), what is the effect of pain mitigation
(I) compared with no pain mitigation (C) on behavioral
(e.g. postures, vocalizations) and non-behavioral (e.g.
blood cortisol, norepinephrine, and b-endorphin levels)
indicators of pain assessed within 60 min of the proce-
dure and between 1 and 24 h of performing the
procedure (O)?’ All outcomes were extracted, regardless
of the panel members’ rankings.
4.1.6 Identification of evidence
Descriptions of the search for evidence, screening for
relevant studies, and data extraction procedures are
presented in (Dzikamunhenga et al., 2014).
4.1.7 Synthesis and presentation of evidence for the
panel meeting
During the January meeting (after data extraction was
completed), the steering committee decided which
outcomes would be included in the guideline develop-
ment process. The results of the ranking exercise and the
review data extraction process, including the frequency
values for the outcomes of interest, were reported to the
steering committee (Dzikamunhenga et al., 2014). The steering
committee made four key decisions at this meeting.
First, only two studies from the same publication
were available for teeth clipping and ear notching. The
committee decided that this was an insufficient amount
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Table 2. The number of voting participants and the results (%) of votes for the outcomes ranked as critical, important, and not important. Plurality ranking indicates the category
with the greatest number of votes
Outcomes n Critical (%) Important (%) Not important (%) Plurality ranking
Behavioral outcomes (<60 min)
Vocalization, call duration 11 27 55 18 Important
Vocalization, call rate 10 10 60 30 Important
Vocalization, main frequency (pitch) 11 45 45 9 Critical/important
Vocalization, peak amplitude 10 60 30 10 Critical
Vocalization, peak frequency (pitch) 11 64 27 9 Critical
Activity event, defecation 9 0 33 67 Not important
Activity event, escape attempts 11 36 36 27 Critical/important
Activity event, urination 9 0 22 78 Not important
Activity state, lying 9 0 56 44 Important
Activity state, playing 10 30 30 40 Not important
Activity state, running 9 0 33 67 Not important
Activity state, sitting 9 0 33 67 Not important
Aggression event 9 0 44 56 Not important
Conditioned avoidance testing 9 0 11 89 Not important
Body movement event, ear flicking 11 27 55 18 Important
Body movement event, head shaking 11 27 55 18 Important
Body movement event, rear end movement such as kicking, scratching 11 27 64 9 Important
Feeding event, suckling/nursing 10 10 30 60 Not important
Feeding event, teat seeking/udder mouthing 9 11 44 44 Important/not important
Feeding event, teeth champing/chewing 9 22 44 33 Important
Non-behavioral outcomes <60 min
Adrenocorticotrophic hormone (ACTH) 8 13 50 38 Important
Beta endorphins 7 29 57 14 Important
Body temperature 7 29 57 14 Important
Cortisol 9 11 56 33 Important
Electrocardiograph readings (ECG) 8 25 63 13 Important
Electroencephalogram readings (EEG) 8 50 38 13 Critical
Epinephrine 8 25 50 25 Important
Haptoglobin 8 0 25 75 Not important
Heart rate 9 33 44 22 Important
Norepinephrine 8 38 50 13 Important
Respiratory rate 9 22 67 11 Important
Substance P 8 50 13 38 Critical
Behavioral outcomes (1–24 h)
Vocalization, call duration 9 0 22 78 Not important
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Table 2 (Continued)
Outcomes n Critical (%) Important (%) Not important (%) Plurality ranking
Vocalization, call rate 9 11 11 78 Not important
Vocalization, main frequency (pitch) 9 11 22 67 Not important
Vocalization, peak amplitude 9 11 22 67 Not important
Vocalization, peak frequency (pitch) 9 11 11 78 Not important
Activity event, defecation 10 0 30 70 Not important
Activity event, escape attempts 9 0 22 78 Not important
Activity event, urination 10 0 20 80 Not important
Activity state, lying 11 27 45 27 Important
Activity state, playing 11 55 36 9 Critical
Activity state, running 11 36 55 9 Important
Activity state, sitting 11 27 45 27 Important
Aggression event 9 0 22 78 Not important
Conditioned avoidance 10 40 20 40 Critical/not important
Body movement event, ear flicking 10 40 40 20 Critical/important
Body movement event, head shaking 11 36 36 27 Critical/not important
Body movement event, rear end movement such as kicking, scratching 11 36 45 18 Important
Feeding event, suckling/nursing 11 45 36 18 Critical
Feeding event, teat seeking/udder mouthing 11 27 55 18 Important
Feeding event, teeth champing/chewing 10 20 60 20 Important
Non-behavioral outcomes, 1–24 h
Adrenocorticotrophic hormone (ACTH) 8 25 63 13 Important
Beta endorphins 7 29 57 14 Important
Body temperature 7 29 57 14 Important
Cortisol 9 33 33 33 All
Electrocardiograph readings (ECG) 8 13 50 38 Important
Electroencephalogram readings (EEG) 8 13 50 38 Important
Epinephrine 7 14 29 57 Not important
Haptoglobin 6 50 33 17 Critical
Heart rate 7 14 43 43 Important/not important
Norepinephrine 7 14 43 43 Important/not important
Respiratory rate 6 0 67 33 Important
Substance P 7 43 29 29 Critical
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of information, and declined to continue data analysis and
recommendation development for these procedures.
Second, only the results of trial arms with a single pain
mitigation strategy were to be included in the review. For
example, if piglets in one arm received lidocaine (local
anesthetic) and meloxicam (NSAID), the results of that
arm were excluded. This decision affected the inclusion
of protocols that included combined use of ketamine
and azaperone, or these drugs combined with others
(e.g. meloxicam).
The third committee decision was that the following
outcomes were the only ones to be summarized for the
panel meeting: cortisol, norepinephrine, b-endorphins,
vocalization (Hz), energy (dB), rate, and pain-associated
behaviors, all at <60 min or between 1 and 24 h of the
procedure. The rationale for presenting these outcomes
was included because they were ranked as important, and
data were available. The intervention types were categor-
ized as general anesthetic, local anesthetic, and NSAID.
The fourth committee decision was that the outcome
‘pain-related behaviors’ would be defined after data
extraction with the assistance of an expert in applied
animal behavior. This approach was necessary because
multiple parameters were often reported in the literature,
but were not always identified as specific outcomes in the
original publication. Multidimensional pain scales have
been identified as more accurate characterizations of the
complexity of an animal’s pain experience (Rutherford,
2002). Therefore, the animal behavior expert preferen-
tially selected the pain index score as the pain behavior
outcome when authors consolidated pain behaviors into
an aggregate pain index score. We randomly selected one
behavior outcome within pain-associated behaviors when
this information was not provided. Pain-related behaviors
were identified as those that would be expected to occur
in the presence of pain, to be absent or occur at low
frequencies in the absence of pain, and to be reduced or
eliminated in the presence of effective anesthesia or
analgesia (Millman, 2013), such as motor patterns
associated with avoidance or removal of noxious stimuli
in the home pen (e.g. wound licking) or in specific
nociception tests (e.g. response to von Frey filaments or
pressure algometry). For example, the review team was
advised to assume that behavior responses directed to the
rear quarters (tail flinching, tail wagging, tail rubbing,
kicking, scooting, and easing the quarters) would be
more sensitive measures of pain resulting from castration
and tail-docking surgeries; hence, we randomly selected a
behavior outcome from this group of responses. The logic
for selecting a single outcome from this group of
behaviors was twofold. First, this was a time-consuming
process since variability in terminology and behavior
observation protocols required each paper to be careful
read to ensure extraction of the correct behavior and units
based on the ethograms used. Second, we wanted to
avoid duplication of what is essentially the same category
of outcome, similar to the logic for our selection of
cortisol as the most common glucocorticoid biomarker
vs. other candidate molecules (e.g. ACTH).
We acknowledge that changes to time budgets
associated with recuperative behavior or ‘sickness moti-
vation’ (Aubert, 1999) are likely to occur post-surgery,
resulting in reductions in feeding and exploratory
motivation and increased rest. However, methodology
for collecting time budget behaviors was highly variable
between studies, and there is little basic knowledge for
how these behaviors would be expected to change during
illness. For example, rest typically increases as part of the
sickness behavior cascade following pro-inflammatory
cytokine release (Millman, 2007). However, disruptions in
rest patterns also occur in response to acute pain, making
meta-analysis of this variable impossible. Hence, many of
the behavior outcomes collected during pain experiments
are at the discovery stage of research during which the
a priori predictions for response are absent. Furthermore,
in some experiments feeding and resting behaviors were
collected with the objective of investigating effects of
productivity versus pain per se, and hence experiments
were not necessarily designed for this latter question. For
these reasons, changes in time budget behaviors were not
extracted for our analysis.
At the February panel meeting, the panel members
received a summary of the literature search, a list of
outcomes extracted from the literature, the results
of the online outcome ranking survey, and forest plots
of 14 outcomes (RevMan, 2012). Each member also
received a tabulated summary of each outcome (Guyatt
et al., 2013c).
4.1.8 Specification and integration of values
The GRADE process was designed for use in human
health. Because we modified it for use for this animal
welfare topic, we clarified the identification of the target
audiences for assessment of benefits and harms, and for
assessment of values and preferences (Schunemann et al.,
2006a). These concepts were discussed at a steering
committee meeting in January, 2013. At that meeting it
was decided that the panel meeting would include a
discussion of these topics with the recommendation that
(1) the balance of benefits and harms for outcomes be
measured in piglets, and (2) the values and preferences
be of the public consumers of pork and citizens (i.e.
voters).
At the February panel meeting, these ideas were
discussed again after two presentations that clarified
this aspect of the recommendation-making process. Dr
Raymond Anthony (University of Alaska Anchorage)
presented, ‘Integrating science into socio-ethical delibera-
tions on animal welfare and care policy: how can
instruments like GRADE help to mitigate pain in farmed
pigs?’, which reviewed epistemological and normative
considerations related to the attitudes of the US public
toward animal welfare and broader societal concerns
(food security, safety, environmental soundness of animal
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agriculture). He also discussed the importance of the use
of the GRADE process to address values and preferences
in a climate of ethical pluralism, risk, and uncertainty.
Dr Glynn Tonsor (Kansas State University) presented
information on the economics of animal welfare issues.
Dr Glynn Tonsor discussed differences between voter
(citizen) and consumer preferences, manifest and theore-
tical willingness to pay, and manifest and theoretical
cost to adopt. Both presentations included discussions of
potential biases present in the evidence base. Systematic
reviews of the values and preferences of consumers
and citizens were not included in the presentations.
The speakers proposed that more research is needed to
understand, (a) consumer and citizen perceptions of on-
farm management processes, (b) public opinions about
the relationship between ethical attitudes toward animals
and their welfare, and what the public considers to be an
acceptable quality of life for farmed animals, and (c) what
drives the relative desirability for alternative animal
production practices among the different public sectors
that consume animal protein and byproducts.
4.1.9 Making judgments about desirable and unde-
sirable effects
The meeting clarified that benefits and harms would be
considered in terms of outcomes that affected the pig, and
that the target audience with respect to values and
preferences would be pork consumers and citizens.
4.1.10 Taking account of equity
Taking account of equity not explicitly considered.
4.1.11 Grading evidence and recommendations
The GRADE working group recommended the approach
used to evaluate the quality of the evidence (Balshem
et al., 2011; Guyatt et al., 2011a, b, c, d, e, f, g, h, 2013a, b,
c; Andrews et al., 2013a, b; Brunetti et al., 2013). The
GRADE system separates the process of grading scientific
evidence to inform recommendations from the process of
making recommendations. Scientific evidence is graded
based on the presence or absence of inconsistency,
indirectness, imprecision, and risk of bias in the evidence
base that contributes to each outcome. Characteristics of
an inconsistent evidence base include a wide variation in
point estimates, lack of overlap between confidence
intervals, and evidence of heterogeneity among studies.
An evidence base displays indirectness when the study
populations, interventions, or outcomes used in the
primary research differ from those defined for the
review. An evidence base is imprecise if results include
wide confidence intervals, which indicates that sample
sizes were not large enough to obtain adequate study
power. Risk of bias is present in an evidence base if
studies fail to report blinding or allocation concealment,
do not account for all subjects, experience a large loss
of subjects to follow up, selectively report outcomes,
use biased recruitment methods, stop the study early,
or use invalidated outcome measures. For this project,
the panel only considered risk of bias resulting
from failure to control for confounding. However, to
ensure the exchangeability of study groups, study
designs were required to include (when relevant)
randomization, stratification for categorical factors (e.g.
sow, litter), and blocking for continuous factors
(e.g. weight, age).
The panel members developed an evidence profile for
each procedure and intervention combination. All parti-
cipants voted on the following domains for each outcome
associated with each intervention and procedure: Risk of
bias (Low or Serious or Very Serious), Indirectness (Low
or Serious or Very Serious), Inconsistency (Low or Serious
or Very Serious), Imprecision (Low or Serious or Very
Serious), Evidence of publication bias (Undetected or
Strongly Suspected).
If the panel members did not achieve a consensus, the
panel was informed and the discussion continued. The
facilitator often invited participants to explain their
reasons for a particular vote or to discuss the GRADE
term further. Group members voted again after this
discussion. If a consensus could not be achieved, the
vote was delayed, and other issues were discussed and
voted upon. This process continued until all outcomes for
each procedure and intervention combination were
assessed (Table 3).
The panel used the voting results to develop recom-
mendations. The body of evidence was downgraded for
domains in the serious category. The body of evidence
was upgraded when control for confounding, a large
effect size, and evidence of a dose–response relationship
were present. An evidence grade for each outcome
resulted from this process. The grades were (language
used by the GRADE working group):
 High quality: further research is very unlikely to change
our confidence in the estimate of effect.
 Moderate quality: further research is likely to have an
important impact on our confidence in the estimate of
effect and may change the estimate.
 Low quality: further research is very likely to have an
important impact on our confidence in the estimate of
effect and is likely to change the estimate.
 Very low quality: we are very uncertain about the
estimate.
The panel did not achieve a consensus for ‘imprecision’
on many occasions during the evidence grading phase.
Significant time and effort were applied to understand the
definition of imprecision. The facilitator suggested that
decisions about imprecision should consider the number
of studies, and the widths of the confidence intervals.
Evidence of imprecision was present if confidence
intervals included different clinical implications. Two
rankings were used to account for this issue. For example,
if the panel could not reach consensus, and the votes
were divided between ‘Serious’ and ‘Very Serious,’
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Table 3. GRADE voting results expressed as percentages for the outcomes and interventions considered for recommendations
CO2/O2 general anesthesia Local anesthesia Non-steroidal anti-inflammatory drugs
Cortisol
(0–60 min)
Cortisol
(1–24 h) b-endorphins
Energy
(0–60 min)
Cortisol
(0–60 min)
Cortisol
(1–24 h)
Energy
(0–60 min)
Pain-like behaviors
(0–60 min)
Risk of bias
Low 17 11 11 75 100 NC 82 94
Serious 83 83 89 25 0 NC 12 6
Very serious 0 6 0 0 0 NC 6 0
Indirectness
Low 83 83 – – – – – –
Serious 6 17 – – – – – –
Very serious 11 0 – – – – – –
Inconsistency
Low 6 83 83 75 94 83 83 83
Serious 89 17 17 19 6 11 17 11
Very serious 6 0 0 6 0 6 0 6
Imprecision
Low 11 17 NC NC 83 94 NC NC
Serious 89 83 NC NC 17 6 NC NC
Very serious 0 0 NC NC 0 0 NC NC
Publication bias
Undetected 83 94 –– – 89 100 83 89
Strongly suspected 17 6 – – 11 0 17 11
Body of work
Very low 94 – NC 94 6 – – –
Low 0 – NC 6 89 – – –
Moderate 6 – NC 0 6 – – –
High 0 – NC 0 0 – – –
Absence of high-quality evidence
Yes 100 – – – 88 – – –
No 0 – – – 12 – – –
Benefits and harms
Yes 76 – – 81 12 – – –
No 24 – – 19 88 – – –
Values and preferences
Yes 100 – – Yes? 88 – – –
No 0 – – 12 – – –
Recommendation
For 0 – – 25 82 – – –
Against 100 – – 75 18 – – –
Recommendation strength
Weak 6 – – 88 82 – – –
Strong 94 – – 12 18 – – –
Nineteen and 18 people voted on days 1 and 2, respectively, because one participant was not present on the final day.
NC=no consensus
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and we considered this uncertainty during the subsequent
voting stage.
After an evidence profile was developed for each
outcome that related to a procedure and intervention
outcomes, the participants then voted about the entire
body of work for each procedure and intervention i.e.
they considered how the intervention affected multiple
outcomes together:
(1) Quality of body of work (Very low or Low or
Moderate or High)
(2) Absence of high-quality evidence (Yes or No)
(3) Uncertainty about the balance of benefits and harms
(Yes or No)
(4) Uncertainty about the values and preferences (Yes or
No)
After establishing these evidence profiles for each
outcome, and grading all outcomes combined for
each procedure and intervention, the panel voted on
the following:
(5) For or against the intervention (For or Against), and
then
(6) The strength of the recommendation (Weak or
Strong).
After voting was completed, the GRADEpro1 (2008)
summary of findings, evidence profiles, and recommen-
dations tables were completed.
4.1.12 Taking account of costs
Panel members included economics during consideration
of values and preferences. The economic costs of
interventions must be absorbed somewhere along the
farm-to-fork continuum (i.e. by producers, packers, food
processors, retailers, and/or consumers/citizens). These
costs affect consumer willingness to pay and producer
willingness to adopt an intervention. The process of
considering resources and costs included weighting the
economic costs and benefits to the public and producers,
and weighting the relative costs against each other for
these stakeholder groups. Panelists did not include
product availability during the consideration of values
and preferences because resource implications were
added to the judgment. This discussion was mostly
limited to the factors that affect the legal availability of
products. For example, some products were not regis-
tered for use for pain mitigation in piglets in the USA, but
they were registered for use in many other countries
(e.g. Canada, Mexico, New Zealand, and the European
Union).
4.1.13 Adaptation, applicability, transferability of
guidelines
Our goal was to provide the evidence and protocol in a
format that would enable others to use the evidence. The
final report provided to the funding agency included
a description of the protocol. The information provided in
this manuscript also represents a component of the
transfer process.
4.1.14 Structure of reports, methods of peer review,
planned methods of dissemination, and implementa-
tion and evaluation of the guidelines
The review team created a draft report that described
research gaps, guideline development, and translation
issues. All steering committee members reviewed and
edited this draft. It was then shared online for comment
from the external participants. After the end of the
comment period, the Iowa State University steering
committee met to discuss the comments, and members
were assigned parts of the review for finalization: research
gaps, guideline development, and translation issues. The
review team then combined the three sections into a
final report, shared it with the external participants for
comment, and then submitted it to the funding agency.
The review team then prepared publications for peer-
review.
4.1.15 GRADE and systematic review training for
panel participants
Opportunities for panelists to become familiar with the
process of systematic review and guideline development
were provided several times prior to the panel meeting:
(a) The review facilitator provided the steering commit-
tee with a presentation about research synthesis and
recommendation development at each full-day plan-
ning meeting.
(b) The review process protocol was distributed for
comment from the participants.
(c) The steering committee and the external participants
(except for the economist and the producers) were
required to verify the validity of the extracted data for
several papers included in the review.
(d) A video tutorial described the data extraction soft-
ware and approach.
(e) Four 5- to 15-min tutorial videos were available
online 7 days prior to the panel meeting. These
tutorials described the GRADE approach and the
criteria for panel member selection.
(f) Evidence synthesis and recommendation develop-
ment were discussed during the first half of the panel
meeting. The topics included identification of sources
of bias in scientific research, how to read a meta-
analysis forest plot, and a description of the domains
used to evaluate research quality: bias, consistency,
imprecision, indirectness, publication bias, magni-
tude of effect, the potential direction of confounding
bias, and evidence of a dose–response effect.
The discussion also included a description of
the domains used for recommendations: quality
of evidence, values and preferences, balance of
benefits and harms to the individual, and resource
implications.
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Table 4. Summary of findings, CO2/O2 anesthesia during castration
Outcomes Illustrative comparative difference in outcomes* (95% CI)
No. of animals
and studies reporting
the outcome
No. of animals and
studies included in
the meta-analysis
Quality of the
evidence (GRADE)**
Cortisol (60 min) The mean cortisol within 60 min of castration
was 33.97 higher in the intervention groups
(95% CI=57.41 lower to 125.35 higher)
240 (five studies)1–3 208 (three studies)1–3 
Very low4
Cortisol (24 h) The mean cortisol 1–24 h after castration was
59.97 lower in the intervention groups (95%
CI=92.78–27.17 lower)
220 (four studies)1,3 188 (two studies)1,3 
Moderate/low5
b-endorphin (60 min) The mean b-endorphin within 60 min of castration was
1.06 higher in the intervention groups (95% CI=0.66
lower to 2.78 higher)
115 (four studies)2,3 115 (two studies)2,3 
Moderate/low5
*The basis for the assumed risk (e.g. the median control group risk across
studies) is provided in the footnotes. The corresponding risk (with 95% confidence interval (CI)) is based on the assumed risk in the comparison group and the relative effect of the
intervention (with 95% CI).
**GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1Randomized, not blinded, and blocked.
2Randomized, not blinded, and not blocked.
3Not randomized, not blinded, and not blocked.
4One study showed a positive effect, favoring the intervention; the other point estimate was positive, but the 95% interval included the null value, 0.
5Concern about the width of the interval.
5
0
A
.
O
’C
o
n
n
o
r
et
al.
(g) Presentations about values and preferences were also
included in the meeting.
5. Recommendations
5.1 Intervention: general anesthesia (CO2/O2)
The panel’s current position is a strong recommendation
against the use of a CO2/O2 general anesthesia mixture
for pain mitigation during castration of 1- to 28-day-old
piglets.
5.1.1 Discussion of recommendation for general
anesthesia (CO2/O2)
Carbon dioxide mixed with oxygen to provide CO2/O2
anesthesia was the only inhalation anesthetic protocol
that satisfied the selection criteria for the GRADE process.
The panel decided to combine the recommendation
about CO2/O2 anesthesia regardless of differences in
application, doses, and flow rates. The GRADE summary
of findings for changes in outcomes associated with CO2/
O2 anesthesia is presented in Table 4. The panel
assessment of the quality of the body of work is presented
in the evidence profile (Table 5). The outcomes with
sufficient evidence were cortisol (within 60 min, and
between 1 and 24 h) and b-endorphins (within 60 min).
The panel could not achieve a consensus about impreci-
sion for the b-endorphin evidence (Table 3). The
recommendation, rationale, and proposal for review are
presented in Table 6.
Three relevant outcomes were available to assess the
effect of CO2/O2 general anesthesia: cortisol up to 60 min
post castration, cortisol between 1 and 24 h, and
b-endorphin up to 60 min post castration (Table 4)
(Lauer et al., 1994; Kohler et al., 1998; Schonreiter et al.,
2000; Muhlbauer et al., 2009). Compared with the control
group, use of the CO2/O2 general anesthesia intervention
was associated with a reduction in each outcome. Four to
five studies that included a total of 115–225 animals were
available for each outcome. However, fewer studies
reported the results in a format that allowed a meta-
analysis to be performed. Overall, the quality of the
evidence for each outcome was rated at very low to
moderate. Risk of bias, inconsistency, indirectness, and
imprecision results are presented in Table 5.
The recommendation and the rationale for use of the
intervention CO2/O2 general anesthesia are presented in
Table 6. The overall quality of the evidence for the use of
CO2/O2 general anesthesia was considered to be very
low. Consideration of three outcomes contributed to this
judgment (i.e. magnitude of the observed effect, impor-
tance of the observed effect, and the potential for biased
results).
The use of general inhalation anesthesia has been
proposed as a method to reduce pain manifestations
associated with castration of piglets aged 1 through
28 days. There was a limited number of studies thatT
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measured cortisol response at 60 min and 24 h, and
b-endorphins at 60 min (Dzikamunhenga et al., 2014)
(Table 4). The panel’s strong recommendation against the
use of CO2/O2 for pain mitigation during castration of
1- to 28-day-old piglets was partly based on this paucity
of reviewable studies. There was also little evidence of
pain mitigation after anesthesia recovery. Carbon dioxide
can produce concentration- and flow rate-dependent pain
and distress during the induction phase of anesthesia.
Carbonic acid produced in respiratory and ocular
membranes stimulates feelings of breathlessness and
direct stimulation of the ion channels in the amygdala
(AVMA, 2013). The quality of information was graded as
low to moderate for evaluation of post-anesthesia cortisol
and b-endorphin levels. The risk:reward ratio was judged
as poor because there were many barriers to successful
anesthetic application in the field (i.e. a wide age-related
range in body weight, the lack of standardized equipment
Table 6. Recommendation against the use of CO2/O2 general anesthesia
Recommendation: the panel’s current recommendation is a strong recommendation against the use of a CO2/O2 general
anesthesia mixture for pain mitigation during castration of piglets 1–28 days of age.
We propose that this recommendation could be revisited in 3–5 years if new, high-quality, research is published that
assesses critical outcomes, replicates the speed of on-farm castration, replicates the spectrum of piglet weights at
castration in US production, and assesses adverse events.
Factor Decision Explanation
Quality of
evidence
Very low Few studies were available to assess the efficacy of this intervention; the
outcomes assessed did not enable the panel to understand the impact of
the pain experience on the animals. If animals are properly anesthetized,
the expectation was that pain was mitigated during the castration
procedure. It is unclear if appropriate anesthesia levels can be
consistently achieved on-farm. Further, it is not known if general
anesthesia during castration results in no change, reduced, or increased
pain manifestations 1–24 h after the procedure.
Balance of
benefits and harms
Potential for harm
outweighs the potential
benefits
General anesthesia is a complex procedure, and clearly the potential
exists for under- or overdosing that would result in either no effect or
increased mortality. In a production setting with different ages and
weights of piglets to process, it is currently unrealistic to expect
producers to rapidly, consistently, and safely administer general
anesthesia with existing tools. Further, the potential for harm to workers
adds an additional concern about the safety of the on-farm use of
general anesthetics for pain mitigation. These concerns were major
drivers for the strength and direction of the recommendation provided
by the panel.
Values and
preferences
Major variation in values
and preferences present
The information about values and preferences was assessed based on
what the panel members thought were perspectives held by consumers
of pork and by citizens generally. There are large variations in how the
consumers and citizens value pain mitigation but there is still little data
to indicate what exactly these groups thought about the moral status of
pain and the necessity of using certain pain mitigation strategies. In
making this assessment, the results from voter initiatives were used as
evidence of citizen values, whereas the observed low willingness to pay
scores observed in the US markets provided dichotomous evidence of
consumer valuations. No direct data about pain mitigation in piglets or
consumer preferences was used. It was also noted that willingness to pay
may be difficult to document in the US market, where there are few
unique entry points for pork with differentiated production processes.
This situation differs from egg production, where more direct market
channels exist for differentiated products, such as cage-free eggs. Given
the current difficulties with implementing general anesthesia on farm, it
is unlikely that more consistency in values and preferences would
change the panel’s recommendation.
Resources The panel did not include a vote on the impact of resources; however,
comment about the issues is warranted. Documentation that adminis-
tration equipment is affordable, reproducible in effect, rapid, applicable
to the production site, and safe for animals and workers would be
required for this to be considered a practical intervention. Coupled with
non-steroidal anti-inflammatory drugs application, general anesthesia
may fit into a pain mitigation strategy for castration.
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and protocols, and variable applicator administration
skills). The risk of mortality from an anesthetic overdose
and the high likelihood that the intervention would
be ineffective also contributed to the low rank. The
likelihood that the negative risk:reward rating could be
improved by additional research was judged to be low.
5.2 Intervention: non-steroidal anti-inflammatory
drugs
The panel’s current position is a weak recommendation
for the use of NSAIDs for pain mitigation during castration
of 1- to 28-day-old piglets.
5.2.1 Discussion of recommendation for non-steroidal
anti-inflammatory drugs
Several NSAIDs were evaluated (e.g. meloxicam, flunixin
meglumine, and carprofen). Cortisol concentrations
(under 60 min, and between 1 and 24 h), vocalization
(dB), and pain-like behaviors between 1 and 24 h were
the outcomes that were available for voting (Table 7)
(Zols et al., 2006; Rebecca et al., 2009; Courboulay et al.,
2010; Sutherland et al., 2010, 2012; Hansson et al., 2011;
Kluivers-Poodt et al., 2012; Reiner et al., 2012; Schwab
et al., 2012; Tenbergen, 2012; Wavreille et al., 2012). The
results for the panel assessment of the quality of the
body of work are reported in the evidence profile
(Table 8). The recommendation, rationale, and proposal
for review of the NSAID recommendations are described
in Table 9.
Indirectness was not included in the voting process,
because there was no evidence of serious indirectness.
The very narrow target population, and the votes of ‘low’
applied across all outcomes and all interventions.
A consensus about imprecision was not achieved for the
vocalization measure (Table 3).
Table 7. Summary of findings for nonsteroidal anti-inflammatory drug (NSAID) use during castration
NSAIDs for pain mitigation during castration of piglets 1–28 of age
Population: Pain mitigation during castration of piglets 1–28 days of age.
Setting: Commercial swine production facilities
Intervention: NSAIDs
Outcomes
Illustrative comparative risks* (95% CI) No. of
participants
(studies)
No. of
participants
(studies)
Quality of
the evidence
(GRADE)**Assumed risk Corresponding risk
Control NSAIDs
Cortisol, 60 min The mean cortisol within 60 min of
castration in the intervention groups
was 93.59 lower (138.44–48.74 lower)
634 (14)1–6 
High7
Cortisol, 24 h The mean cortisol 1–24 h after
castration in the intervention groups
was 39.17 lower (51.87–26.47 lower)
441 (9)1,2,4–6 295 (71,3,4) 
Moderate8
Vocalization (dB),
60 min
The mean vocalization (dB) within
60 min of castration in the intervention groups
was 47.4 higher (54.03 lower to 148.82 higher)
357 (5)1–3,5 342 (23) 
High7
Pain-like
behaviours 24 h
The mean pain-like behaviours 1–24 h after
castration in the intervention groups was
0.30 standard deviations higher
(0 to 0.59 higher)
280 (5)1–3,5 180 (3)1 
High/moderate
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in the footnotes.
The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: Confidence interval.
**GRADE Working Group grades of evidence:
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is
likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1Randomized, blinded, and blocked.
2Randomized, blinded, and unblocked.
3Randomized, not blinded, and blocked.
4Randomized, not blinded, and not blocked.
5Nonrandomized, not blinded, and blocked.
6Nonrandomized, not blinded, and not blocked.
7No explanation was provided.
850% failed to include information about controlling for important confounders and blinding.
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Table 8. Evidence profiles for non-steroidal anti-inflammatory drugs during castration
Quality assessment Number of piglets
Quality Importance
No of
studies Design Risk of bias Inconsistency Indirectness Imprecision
Other
considerations Intervention Control
Cortisol, 60 min
11 Randomized
trials1–12
No serious
risk of bias
No serious
inconsistency
No serious
indirectness
No serious
imprecision
None 233 255 
High
Important
Cortisol, 24 h
7 Randomized
trials1,2,7,9–12
Serious13 No serious
inconsistency
No serious
indirectness
No serious
imprecision
None 138 157 
Moderate
Important
Vocalization (dB), 60 min
2 Randomized
trials7,8
No serious
risk of bias
No serious
inconsistency
No serious
indirectness
No serious
imprecision
None 171 171 
High
Not important
Pain-like behaviors, 24 h
3 Randomized
trials1–3
No serious
risk of bias
No serious
inconsistency
No serious
indirectness
Serious14 None 90 90 
Moderate/High
Not rated
1Randomized, blinded, and blocked.
2Randomized, blinded, and blocked.
3Randomized, blinded, and blocked.
4Randomized, blinded, and blocked.
5Randomized, blinded, and blocked.
6Randomized, blinded, and not blocked.
7Randomized, not blinded, and blocked.
8Randomized, not blinded, and blocked.
9Randomized, not blinded, and not blocked.
10Randomized, not blinded, and not blocked
11Randomized, not blinded, and not blocked.
12Randomized, not blinded, and not blocked.
13Approximately 50% of the studies failed to include information about controlling for important confounders and blinding.
14No consensus was reached, so it was recorded as high/moderate.
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Meloxicam was the NSAID most commonly studied for
pain mitigation during castration. Given the mechanism of
action of NSAIDs, this class of drugs is not likely to
mitigate incisional pain transmission via nerves, because
they generally transfer stimuli as electric pulses (Coetzee,
2013b). These rapid transmissions begin almost immedi-
ately after castration. NSAIDs are more likely to affect
inflammatory pain stimuli that are transmitted as a
consequence of the production of cytokines and pros-
taglandins when cell walls are damaged and metabolized
(Coetzee, 2013a). NSAIDs interfere with the enzymes
involved in the synthesis and metabolism of prostaglan-
dins, and change the ratios of cytokine concentrations
(Ochroch et al., 2003; Fraccaro et al., 2013). Specific
cytokines vary in the degree of pain produced, so overall
pain perception is affected by the cytokine ratio. The
NSAIDs findings were consistent with this understanding
(Table 11). Mean cortisol levels were lower at 60 min
and at 24 h after castration, but vocalization energy
was higher during castration. Greater frequency of
Table 9. Recommendation for use of non-steroidal anti-inflammatory drugs (NSAIDs) during castration
Recommendation: The panel’s current recommendation is a weak recommendation for the use of NSAIDs for pain
mitigation during castration of piglets 1–28 days of age.
We propose that this recommendation about the use of NSAIDs as an approach to castration could be revisited in
1–2 years if new products become available on the US market, and if outcomes critical for long-term pain mitigation
are included in the studies
Factor Decision Explanation
Quality of
evidence
Low There is an absence of critical outcomes measured for this intervention. This is an
intervention designed to mitigate pain 1–24 h after the procedure. The
recommendation means the panel placed high value on the cortisol results for this
time frame. It was recognized by the panel that cortisol is not a specific indicator of
pain, and validated pain assessment measures are needed to more fully assess the
benefits of NSAID administration to alleviate the pain associated with castration.
The vocalization results indicate that NSAIDs do not mitigate the acute pain
associated with the procedure. The vocalization results were not unexpected, given
the mechanism of action of these products but provided another reason that the
recommendation was weak rather than strong for these products
Balance of
benefits and
harms
The potential for benefit
outweighs the potential
harms
The panel felt that the likely benefits outweighed the harms for NSAIDs. Unlike
general anesthesia, the potential for overdose is minimal. Current NSAID products
provide a reasonable margin of product safety for published dose regimens.
Additionally, the products are routinely applied via commonly used routes of
administration in commercial swine production facilities. There is a limited
expectation of benefit for incisional pain with benefits limited to the reduction of
inflammatory pain after the procedure
Values and
preferences
Major variations in values
and preferences present
The information about values and preferences was assessed based on what the
panel members thought were perspectives held by consumers of pork and by
citizens generally. There are large variations in how the consumers and citizens
value pain mitigation but there is still little data to indicate what exactly these
groups thought about the moral status of pain and the necessity of using certain
pain mitigation strategies. In making this assessment, the results from voter
initiatives were used as evidence of citizen values, whereas the observed low
willingness to pay scores observed in the US and overseas markets provided
dichotomous evidence of consumer valuations. No direct data about pain
mitigation in piglets or consumer preferences was used. It was also noted that
willingness to pay may be difficult to document in the US market, where there are
few unique entry points for pork with differentiated production processes. This
situation differs from egg production, where more direct market channels exist for
differentiated products, such as cage-free eggs, became available that better
clarified the preferences of pork consumers and citizen this would potential
strengthen the panel’s recommendation. If data became available that clarified the
preferences of pork consumers and citizens, the panel’s recommendation could be
strengthened
Resources Currently, the absence of an FDA-registered product for pain mitigation is a major
barrier that must be resolved. The primary impediment to regulatory approval for
pain indications is the absence of validated methods for pain assessment in swine.
Similarly, several of the products under consideration are considered prescription
drugs. Such a designation makes their widespread use in production settings more
difficult and expensive to manage
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pain-associated behaviors were observed in the interven-
tion group (at 24 h). A delay in the start of cytokine-
mediated pain is expected, but the relative rate at which
each subsides is unknown. A pain-associated behavior
observed at 24 h may not represent a specific cytokine-
related response, or be an accurate indicator of NSAID
activity.
The quality of the NSAID studies was rated as high,
but the panel concluded that an insufficient number of
outcomes had been evaluated for this intervention. Most
of the panel decisions relied primarily on cortisol as an
outcome. Among the 14 outcomes characterized as
important, only the outcomes cortisol and vocalisation
were evaluated. Consequently, the overall quality of the
evidence for this intervention was judged to be low.
Additional research and assessment of NSAIDs for critical
outcomes would likely strengthen the evidence required
to formulate recommendations. For physiological impact,
the potential for benefits was judged to outweigh the
potential for harms. However, from a resource perspec-
tive the lack of an FDA-approved analgesic compound for
use in food animals was considered to be a major barrier
to implementation.
5.3 Intervention: local anesthesia – lidocaine
The panel’s current recommendation is a weak recommen-
dation against the use of lidocaine as a pain mitigation
strategy during castration of piglets aged 1–28 days.
5.3.1 Discussion of recommendation for lidocaine
Lidocaine was the only local anesthesia pain mitigation
strategy that was identified, and vocalization (dB) was the
only outcome available for voting (Tables 3 and 10) (White
et al., 1995; Horn et al., 1999; Marx et al., 2003; Rittershaus
et al., 2009; Hansson et al., 2011; Kluivers-Poodt et al.,
2012; Temple et al., 2012). The voting process was not
used for indirectness because no serious indirectness of
evidence was found. The consensus was that there was a
low risk of bias among the studies that reported this
outcome and that the evidence demonstrated low incon-
sistency. The panelists agreed (94%) that the overall quality
of the body of work was very low (Table 11). Table 12
presents the recommendation, rationale, and proposal for
review of the lidocaine recommendations.
The panel considered the use of lidocaine for pain
mitigation during castration of piglets 1–28 days of age.
Cortisol levels 60 min after surgery were used as evidence
of efficacy of pain relief. Only two studies measured
effects, but both found that cortisol levels were lower in
treatment pigs. The panel assigned a score of moderate
quality to this research (Table 12). Vocalization scores
indicated that pain during castration was not mitigated
by lidocaine anesthesia. The quality of evidence to
support this intervention was judged to be very low.
A risk:reward ratio could not be determined from the
available evidence. However, a minimal number of
rewards were reported, so the likelihood of a positive
ratio was low. Although there were a small number of
studies available for review, their results were graded
Table 10. Summary of findings for local anesthesia during castration
Local anesthesia for pain mitigation during castration of piglets 1–28 days of age.
Population: Pain mitigation during castration of piglets 1–28 days of age
Setting: Commercial swine production facilities
Intervention: Local anesthesia
Outcomes
Illustrative comparative risks* (95% CI)
No. of
participants
(studies)
No. of participants
in the meta-analysis
(studies)
Quality of the
evidence (GRADE)**
Corresponding risk
Local anesthesia
Energy 60 min The mean vocalization energy (dB)
within 60 min of castration was
8.8 lower for the intervention groups
(10.86–6.74 lower)
342 (4)1,2 342 (2)1  Moderate
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in the footnotes.
The corresponding risk (with 95% confidence interval) is based on the assumed risk in the comparison group and the
relative effect of the intervention (with 95% CI).
CI: Confidence interval.
**GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may
change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is
likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
1Randomized, not blinded, and blocked.
2Not randomized, not blinded, and blocked.
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as moderate. Therefore, the panel concluded that this
intervention should be studied further (i.e. measurement
of a range of critical outcomes and assessment of the
potential for adverse events). The results of these new
studies combined with older studies should be re-
evaluated in several years to determine if the evidence
base for local anesthesia has changed and different
conclusions would be reached.
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Table 12. Use of lidocaine during castration
Recommendation: The panel’s current recommendation is a weak recommendation against the use of lidocaine for pain
mitigation during castration of piglets 1–28 days of age.
We propose that this recommendation about the use of local anesthetic as an approach to pain mitigation during
castration could be revisited in 1–2 years if new high-quality studies that assessed critical outcomes, replicated the on-
farm speed of castration, approximated the spectrum of piglet weights to be castrated in the US production, and assessed
possible adverse events are published, and if information required for appropriate off-label use or registration for use to
mitigate pain in piglets becomes available
Factor Decision Explanation
Quality of
evidence
Very low Lidocaine is an intervention designed to mitigate pain in the short term, that
is, 1–2 h after the procedure. There was an absence of information about the
a priori identified critical outcomes for this intervention. For this intervention,
we would expect that only incisional pain associated with the procedure
would be mitigated. Two studies did indicate that administration of lidocaine
did reduce vocalization, as measured by call energy. However, there was
debate among the panel about the value of this outcome; therefore, the
evidence base was considered very low
Balance of
benefits
and harms
Uncertainty that the potential
benefits were greater than
the harms
The uncertainty expressed here about the balance of benefits and harms by
the panel was related to a failure to document the extent of benefits. The
benefit to the piglet is that, provided the extra application steps necessary to
utilize this product where utilized, local anesthetic would mitigate pain in
the short term. However, for two reasons, the panel proposed that those
benefits may not be as great as expected. First, in the US production system,
there is reluctance and practical difficulties to taking the extra steps to
administer lidocaine before the procedure. If these steps are not taken, little
real benefit for the piglet is realised. Further, based on the mechanism of
action rather than on empirical studies in piglets, we would not expect that
inflammatory pain associated with castration to be mitigated by lidocaine.
These uncertainties weakened the recommendations. Possible harms to the
piglet were thought to be minimal, as lidocaine is widely used in human and
animal health, and has a reasonable margin of product safety; therefore, the
harms that would occur are minimal. It is also theoretically possible that
lidocaine could adversely affect wound healing
Values and
preferences
Major variation in values and
preferences
The information about values and preferences was assessed based on what
the Panel thought were perspectives held by consumers of pork and by
citizens generally. There are large variations in how the consumers and
citizens value pain mitigation but there is still little data to indicate what
exactly these groups thought about the moral status of pain and the necessity
of using certain pain mitigation strategies. In making this assessment, the
results from voter initiatives were used as evidence of citizen values, whereas
the observed low willingness to pay scores observed in the US markets
provided dichotomous evidence of consumer valuations. No direct data
about pain mitigation in piglets or consumer preferences was used. It was
also noted that willingness to pay may be difficult to document in the US
market, where there are few unique entry points for pork with differentiated
production processes. This situation differs from egg production, where more
direct market channels exist for differentiated products, such as cage-free
eggs
Resources As with non-steroidal anti-inflammatory drugs, the absence of FDA-
registered products for local anesthesia to reduce pain in swine is a major
barrier that must be resolved if local anesthetic products are to be adopted.
Lidocaine is a prescription drug requiring regulation at point of use to address
untoward effects from its use. This is not a trivial barrier to adoption, because
extra label use of products in the USA falls under the jurisdiction of
AMDUCA. Among the processes required by AMDUCA, veterinarians must
provide producers with withdrawal times for meat production. Such
information is difficult to obtain, as methods of determining meat with-
drawals are not harmonized across countries, and withholding times used in
swine production elsewhere cannot be guaranteed to meet FDA require-
ments. For producers, extra-label drug use requires the maintenance of
records that indicate the animals treated and the dose. Such a designation
makes the widespread use of lidocaine in US production settings difficult and
expensive to manage for the producer and legally difficult for veterinarians.
The failure to document great benefit combined with resource issues led to
a weak recommendation against the use of local anesthetic
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